ENTPD3 and renal cell carcinoma: The in vitro functional assays validated that overexpression of ENTPD3-AS1 significantly suppressed RCC cell proliferation (Fig. 4A, B) and colony formation (Fig. 4C, D) in 786-O and A498 cells.